Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/14/11/1654/478466/mdg457.pdf
Reference14 articles.
1. Multimodal therapy for the management of nonpelvic, localized Ewing’s sarcoma of bone: Intergroup Study IESS-II;Burgert;J Clin Oncol,1990
2. Multimodal therapy for the management of primary, nonmetastatic Ewing’s sarcoma of bone: a long-term follow up of the first intergroup study;Nesbit;J Clin Oncol,1990
3. The response to initial chemotherapy as a prognostic factor in localized Ewing’s sarcoma;Oberlin;Eur J Cancer Clin Oncol,1985
4. Ewing’s sarcoma treatment in Scandinavia 1984–1990: ten-year results of the Scandinavian Sarcoma Group protocol SSGIV;Nilbert;Acta Oncol,1998
5. Ifosfamide-containing chemotherapy in Ewing’s sarcoma: the second United Kingdom Children’s Cancer Study Group and the Medical Research Council Ewing’s Tumor Study;Craft;J Clin Oncol,1998
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ewing Sarcoma Developed at the Site of Previous Mast Cell Proliferation;Cureus;2023-12-14
2. Phase 1 study of cabozantinib in combination with topotecan–cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma;Pediatric Blood & Cancer;2023-09-16
3. Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board;Cancer;2023-07-05
4. Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma;Cancer Medicine;2023-06-12
5. High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience;Medicine;2022-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3